Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Library Location
Language
Publication DateRevista Cubana de Medicina, ISSN 0034-7523, 2014, Volume 53, Issue 1, pp. 14 - 24
Journal Article
Details 
Digital rights
Loading RightsBritish Journal of Haematology, ISSN 0007-1048, 04/2010, Volume 149, Issue 2, pp. 209 - 220
thrombophilia | venous thrombosis | anticoagulation | Thrombophilia | Anticoagulation | Venous thrombosis | FAMILIAL THROMBOPHILIA | RISK-FACTORS | UPPER-EXTREMITY | INHERITED ANTITHROMBIN DEFICIENCY | DEEP-VEIN THROMBOSIS | HORMONE REPLACEMENT THERAPY | PROSPECTIVE COHORT | FACTOR-V-LEIDEN | RECURRENT VENOUS THROMBOEMBOLISM | PROTEIN-S DEFICIENCY | HEMATOLOGY | Thrombophilia - genetics | Genetic Predisposition to Disease | Pregnancy Complications, Hematologic - prevention & control | Venous Thrombosis - therapy | Estrogens | Humans | Risk Factors | Thrombophilia - complications | Venous Thrombosis - etiology | Contraindications | Pregnancy | Thrombophilia - diagnosis | Blood Coagulation Tests - methods | Female | Practice guidelines (Medicine) | Anticoagulants (Medicine) | Index Medicus
Journal Article
Details
Digital rights
Loading RightsAmerican Journal of Clinical Pathology, ISSN 0002-9173, 03/2017, Volume 147, Issue suppl_2, pp. S158 - S159
Journal Article
Details
Digital rights
Loading RightsImmunity, ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 633 - 645
Combination antiretroviral therapy for HIV infection improves immune function and eliminates the risk of AIDS-related complications but does not restore full...
MUCOSAL IMMUNE RECONSTITUTION | RECEIVING ANTIRETROVIRAL THERAPY | MONOCYTE ACTIVATION | INTESTINAL EPITHELIAL BARRIER | CD4(+) T-CELLS | CARDIOVASCULAR-DISEASE EVENTS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | MICROBIAL TRANSLOCATION | D-DIMER | Intestinal Mucosa - physiopathology | Age Factors | Humans | Protein Biosynthesis - immunology | HIV - immunology | Monocytes - immunology | Liver - physiopathology | Thrombophilia - etiology | Thrombophilia - immunology | HIV Infections - immunology | Liver - immunology | Intestinal Mucosa - immunology | Monocytes - pathology | Anti-Inflammatory Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Thrombophilia - drug therapy | Thrombophilia - physiopathology | Inflammation - immunology | Immunity, Innate | Inflammation - etiology | Models, Immunological | Multiple Organ Failure - etiology | HIV Infections - complications | Multiple Organ Failure - immunology | HIV Infections - drug therapy | HIV Infections - physiopathology | Multiple Organ Failure - physiopathology | Chronic Disease | Inflammation - physiopathology | Highly active antiretroviral therapy | AIDS vaccines | Analysis | Protein biosynthesis | Inflammation | HIV (Viruses) | Health aspects | HIV infection | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV | Mortality | Index Medicus
MUCOSAL IMMUNE RECONSTITUTION | RECEIVING ANTIRETROVIRAL THERAPY | MONOCYTE ACTIVATION | INTESTINAL EPITHELIAL BARRIER | CD4(+) T-CELLS | CARDIOVASCULAR-DISEASE EVENTS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | MICROBIAL TRANSLOCATION | D-DIMER | Intestinal Mucosa - physiopathology | Age Factors | Humans | Protein Biosynthesis - immunology | HIV - immunology | Monocytes - immunology | Liver - physiopathology | Thrombophilia - etiology | Thrombophilia - immunology | HIV Infections - immunology | Liver - immunology | Intestinal Mucosa - immunology | Monocytes - pathology | Anti-Inflammatory Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Thrombophilia - drug therapy | Thrombophilia - physiopathology | Inflammation - immunology | Immunity, Innate | Inflammation - etiology | Models, Immunological | Multiple Organ Failure - etiology | HIV Infections - complications | Multiple Organ Failure - immunology | HIV Infections - drug therapy | HIV Infections - physiopathology | Multiple Organ Failure - physiopathology | Chronic Disease | Inflammation - physiopathology | Highly active antiretroviral therapy | AIDS vaccines | Analysis | Protein biosynthesis | Inflammation | HIV (Viruses) | Health aspects | HIV infection | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV | Mortality | Index Medicus
Journal Article
Details
Digital rights
Loading RightsCirculation, ISSN 0009-7322, 07/2003, Volume 108, Issue 3, pp. 313 - 318
Background-We have shown that normal D-dimer levels obtained after the discontinuation of oral anticoagulant treatment (OAT) has a high negative predictive...
Thrombophilia | Thromboembolism | Thrombosis | Fibrin fibrinogen degradation product | FAMILIAL THROMBOPHILIA | VEIN THROMBOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | thromboembolism | RISK-FACTORS | INTENSITY | fibrin fibrinogen degradation product | FIRST EPISODE | thrombophilia | thrombosis | FACTOR-V-LEIDEN | THERAPY | GENE | PULMONARY-EMBOLISM | MUTATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Predictive Value of Tests | Prospective Studies | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Secondary Prevention | Venous Thrombosis - complications | Thrombophilia - complications | Thromboembolism - prevention & control | Time Factors | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Child | Thrombophilia - drug therapy | Thrombophilia - genetics | Risk Assessment | Administration, Oral | Fibrin Fibrinogen Degradation Products - analysis | Mass Screening | Thrombophilia - blood | Adolescent | Thromboembolism - complications | Heterozygote | Aged | Cohort Studies | Index Medicus | Abridged Index Medicus
Thrombophilia | Thromboembolism | Thrombosis | Fibrin fibrinogen degradation product | FAMILIAL THROMBOPHILIA | VEIN THROMBOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | thromboembolism | RISK-FACTORS | INTENSITY | fibrin fibrinogen degradation product | FIRST EPISODE | thrombophilia | thrombosis | FACTOR-V-LEIDEN | THERAPY | GENE | PULMONARY-EMBOLISM | MUTATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Predictive Value of Tests | Prospective Studies | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Secondary Prevention | Venous Thrombosis - complications | Thrombophilia - complications | Thromboembolism - prevention & control | Time Factors | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Child | Thrombophilia - drug therapy | Thrombophilia - genetics | Risk Assessment | Administration, Oral | Fibrin Fibrinogen Degradation Products - analysis | Mass Screening | Thrombophilia - blood | Adolescent | Thromboembolism - complications | Heterozygote | Aged | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading RightsJournal of Thrombosis and Haemostasis, ISSN 1538-7933, 06/2019, Volume 17, Issue 6, pp. 1007 - 1009
Journal Article
Details
Digital rights
Loading RightsEuropean Journal of Human Genetics, ISSN 1018-4813, 07/2018, Volume 26, Issue 9, pp. 1 - 1398
This article was originally published under an incorrect license. This has now been amended and is available under a CC BY-NC-ND 4.0 license. The PDF and HTML...
Thrombophilia | Cancer
Thrombophilia | Cancer
Journal Article
Details
Digital rights
Loading RightsPro-thrombotic States in Stroke, 12/2002
A large number of prothrombotic states both inherited and acquired, have been linked with ischemic cerebrovascular disease. Inherited deficiencies of the...
Stroke, Thrombophilia, Prothrombotic stroke, Cerebral infarction
Stroke, Thrombophilia, Prothrombotic stroke, Cerebral infarction
Journal
Details
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 8/2018, Volume 46, Issue 2, pp. 238 - 243
The predictive value of factor V Leiden and the G20210A prothrombin mutation regarding recurrent venous thromboembolism (VTE) is limited and does not influence...
Hospital data | In-hospital mortality | Medicine & Public Health | Hematology | Cardiology | Venous thromboembolism | Thrombophilia testing | Length of stay | CARDIAC & CARDIOVASCULAR SYSTEMS | GUIDELINES | PHYSICIANS | ANTITHROMBOTIC THERAPY | INHERITED THROMBOPHILIA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ISCHEMIC-STROKE | Length of Stay | Genetic Predisposition to Disease | Genetic Testing | Hospital Mortality | Humans | Middle Aged | Practice Patterns, Physicians | Factor V | Thrombophilia - diagnosis | Venous Thromboembolism - genetics | Hospitals | Adult | Prothrombin - genetics | Mutation | Medical research | Care and treatment | Physicians | Analysis | Mortality | Prothrombin | Medicine, Experimental | Thrombin | Thromboembolism | Coagulation factors | Thrombophilia | Diagnosis | Index Medicus
Hospital data | In-hospital mortality | Medicine & Public Health | Hematology | Cardiology | Venous thromboembolism | Thrombophilia testing | Length of stay | CARDIAC & CARDIOVASCULAR SYSTEMS | GUIDELINES | PHYSICIANS | ANTITHROMBOTIC THERAPY | INHERITED THROMBOPHILIA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ISCHEMIC-STROKE | Length of Stay | Genetic Predisposition to Disease | Genetic Testing | Hospital Mortality | Humans | Middle Aged | Practice Patterns, Physicians | Factor V | Thrombophilia - diagnosis | Venous Thromboembolism - genetics | Hospitals | Adult | Prothrombin - genetics | Mutation | Medical research | Care and treatment | Physicians | Analysis | Mortality | Prothrombin | Medicine, Experimental | Thrombin | Thromboembolism | Coagulation factors | Thrombophilia | Diagnosis | Index Medicus
Journal Article
Details
Digital rights
Loading Rights
10.
Full Text
Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities
Circulation, ISSN 0009-7322, 08/2004, Volume 110, Issue 5, pp. 566 - 570
Background - One third of cases of upper-extremity deep vein thrombosis (DVT) are primary, ie, they occur in the absence of central venous catheters or cancer....
Thrombophilia | Thrombosis | Risk factors | DIAGNOSIS | risk factors | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTHROMBIN-GENE | VENOUS THROMBOSIS | PREVALENCE | HYPERCOAGULABLE STATES | thrombophilia | thrombosis | INCREASE | MUTATION | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY | ORAL-CONTRACEPTIVES | Hyperhomocysteinemia - epidemiology | Activated Protein C Resistance - epidemiology | Recurrence | Prevalence | Follow-Up Studies | Humans | Middle Aged | Male | Antithrombin III Deficiency - genetics | Life Tables | Thrombophilia - epidemiology | Antiphospholipid Syndrome - complications | Thrombophilia - complications | Protein S Deficiency - genetics | Antiphospholipid Syndrome - epidemiology | Adult | Female | Antithrombin III Deficiency - complications | Activated Protein C Resistance - genetics | Thrombophilia - drug therapy | Thrombophilia - genetics | Contraceptives, Oral, Hormonal - adverse effects | Protein S Deficiency - complications | Antithrombin III Deficiency - epidemiology | Risk Factors | Activated Protein C Resistance - complications | Anticoagulants - therapeutic use | Venous Thrombosis - etiology | Disease-Free Survival | Mass Screening | Venous Thrombosis - epidemiology | Adolescent | Protein S Deficiency - epidemiology | Arm - blood supply | Hyperhomocysteinemia - genetics | Prothrombin - genetics | Thrombophilia - chemically induced | Factor V - genetics | Mutation | Hyperhomocysteinemia - complications | Cohort Studies | Index Medicus | Abridged Index Medicus
Thrombophilia | Thrombosis | Risk factors | DIAGNOSIS | risk factors | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTHROMBIN-GENE | VENOUS THROMBOSIS | PREVALENCE | HYPERCOAGULABLE STATES | thrombophilia | thrombosis | INCREASE | MUTATION | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY | ORAL-CONTRACEPTIVES | Hyperhomocysteinemia - epidemiology | Activated Protein C Resistance - epidemiology | Recurrence | Prevalence | Follow-Up Studies | Humans | Middle Aged | Male | Antithrombin III Deficiency - genetics | Life Tables | Thrombophilia - epidemiology | Antiphospholipid Syndrome - complications | Thrombophilia - complications | Protein S Deficiency - genetics | Antiphospholipid Syndrome - epidemiology | Adult | Female | Antithrombin III Deficiency - complications | Activated Protein C Resistance - genetics | Thrombophilia - drug therapy | Thrombophilia - genetics | Contraceptives, Oral, Hormonal - adverse effects | Protein S Deficiency - complications | Antithrombin III Deficiency - epidemiology | Risk Factors | Activated Protein C Resistance - complications | Anticoagulants - therapeutic use | Venous Thrombosis - etiology | Disease-Free Survival | Mass Screening | Venous Thrombosis - epidemiology | Adolescent | Protein S Deficiency - epidemiology | Arm - blood supply | Hyperhomocysteinemia - genetics | Prothrombin - genetics | Thrombophilia - chemically induced | Factor V - genetics | Mutation | Hyperhomocysteinemia - complications | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading Rights
11.
Full Text
EP16.18: Pregnancy association of abnormal Doppler indices with inherited thrombophilia
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 09/2017, Volume 50, Issue S1, pp. 337 - 337
Journal Article
Details
Digital rights
Loading RightsThe Lancet, ISSN 0140-6736, 03/2003, Volume 361, Issue 9361, pp. 901 - 908
Our aim was to assess the strength of the controversial association between thrombophilia and fetal loss, and to examine whether it varies according to the...
FIRST-TRIMESTER | WOMEN | MEDICINE, GENERAL & INTERNAL | FACTOR-V-LEIDEN | ACTIVATED PROTEIN-C | VENOUS THROMBOSIS | RISK FACTOR | RESISTANCE | RECURRENT PREGNANCY LOSS | GENE MUTATION | NIMES OBSTETRICIANS | Thrombophilia - genetics | Prevalence | Factor V - metabolism | Abortion, Habitual - epidemiology | Humans | Risk Factors | Thrombophilia - complications | Pregnancy | Factor V Deficiency - complications | Female | Factor V - genetics | Abortion, Habitual - etiology | Thrombophilia - metabolism | Risk factors | Fetal death | Deaths | Fetuses | Illnesses | Disorders | Protein C | Activated protein C | Protein deficiency | Thrombosis | Antithrombin | Proteins | Studies | Coagulation factors | Thrombophilia | Factor V | Womens health | Prothrombin | Protein S | Mutation | Health risk assessment | Index Medicus | Abridged Index Medicus
FIRST-TRIMESTER | WOMEN | MEDICINE, GENERAL & INTERNAL | FACTOR-V-LEIDEN | ACTIVATED PROTEIN-C | VENOUS THROMBOSIS | RISK FACTOR | RESISTANCE | RECURRENT PREGNANCY LOSS | GENE MUTATION | NIMES OBSTETRICIANS | Thrombophilia - genetics | Prevalence | Factor V - metabolism | Abortion, Habitual - epidemiology | Humans | Risk Factors | Thrombophilia - complications | Pregnancy | Factor V Deficiency - complications | Female | Factor V - genetics | Abortion, Habitual - etiology | Thrombophilia - metabolism | Risk factors | Fetal death | Deaths | Fetuses | Illnesses | Disorders | Protein C | Activated protein C | Protein deficiency | Thrombosis | Antithrombin | Proteins | Studies | Coagulation factors | Thrombophilia | Factor V | Womens health | Prothrombin | Protein S | Mutation | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading RightsJournal of the Neurological Sciences, ISSN 0022-510X, 2017, Volume 377, pp. 227 - 233
Abstract Introduction Data are limited on the optimal management of cryptogenic TIA/stroke patients with a patent foramen ovale (PFO) ± inter-atrial septal...
Neurology | Patent foramen ovale | Inter-atrial septal aneurysm | Arterial and venous thrombophilia screening, TIA | Ischaemic stroke | PERCUTANEOUS CLOSURE | PARADOXICAL EMBOLISM | FACTOR-VIII | ASPIRIN PLUS DIPYRIDAMOLE | TIA | HEALTH-CARE PROFESSIONALS | NEUROSCIENCES | SECONDARY PREVENTION | CLINICAL NEUROLOGY | CRYPTOGENIC STROKE | HOMOCYSTEINE LEVELS | FACTOR-V-LEIDEN | Arterial and venous thrombophilia screening | CEREBRAL-ISCHEMIA | Heart Septal Defects, Ventricular - complications | Echocardiography | Foramen Ovale, Patent - therapy | Ischemic Attack, Transient - therapy | Prevalence | Prospective Studies | Humans | Middle Aged | Risk Factors | Stroke - complications | Male | Treatment Outcome | Thrombophilia - epidemiology | Thrombophilia - etiology | Ischemic Attack, Transient - complications | Thrombophilia - diagnosis | Fibrinolytic Agents - therapeutic use | Adult | Female | Aged | Foramen Ovale, Patent - complications | Longitudinal Studies | Stroke - therapy | Index Medicus
Neurology | Patent foramen ovale | Inter-atrial septal aneurysm | Arterial and venous thrombophilia screening, TIA | Ischaemic stroke | PERCUTANEOUS CLOSURE | PARADOXICAL EMBOLISM | FACTOR-VIII | ASPIRIN PLUS DIPYRIDAMOLE | TIA | HEALTH-CARE PROFESSIONALS | NEUROSCIENCES | SECONDARY PREVENTION | CLINICAL NEUROLOGY | CRYPTOGENIC STROKE | HOMOCYSTEINE LEVELS | FACTOR-V-LEIDEN | Arterial and venous thrombophilia screening | CEREBRAL-ISCHEMIA | Heart Septal Defects, Ventricular - complications | Echocardiography | Foramen Ovale, Patent - therapy | Ischemic Attack, Transient - therapy | Prevalence | Prospective Studies | Humans | Middle Aged | Risk Factors | Stroke - complications | Male | Treatment Outcome | Thrombophilia - epidemiology | Thrombophilia - etiology | Ischemic Attack, Transient - complications | Thrombophilia - diagnosis | Fibrinolytic Agents - therapeutic use | Adult | Female | Aged | Foramen Ovale, Patent - complications | Longitudinal Studies | Stroke - therapy | Index Medicus
Journal Article
Details
Digital rights
Loading RightsHypertension, ISSN 0194-911X, 12/2005, Volume 46, Issue 6, pp. 1270 - 1274
The role of thrombophilia in the pathogenesis of preeclampsia is controversial. The aim of this case-controlled study was to determine whether thrombophilia...
Thrombophilia | Perinatal outcome | Maternal outcome | Preeclampsia | ACTIVATED PROTEIN-C | PROTHROMBIN G20210A MUTATION | GENETIC RISK-FACTORS | maternal outcome | preeclampsia | ELEVATED LIVER-ENZYMES | METHYLENETETRAHYDROFOLATE REDUCTASE | thrombophilia | GESTATIONAL HYPERTENSION | FACTOR-V-LEIDEN | FETAL INHERITED THROMBOPHILIAS | ANTIPHOSPHOLIPID-ANTIBODIES | PERIPHERAL VASCULAR DISEASE | perinatal outcome | LOW PLATELET COUNT | Pregnancy | Severity of Illness Index | Thrombophilia - genetics | Risk Assessment | Humans | Female | Heterozygote | Pre-Eclampsia - physiopathology | Thrombophilia - complications | Case-Control Studies | Pregnancy Outcome | Thrombophilia - etiology | Index Medicus
Thrombophilia | Perinatal outcome | Maternal outcome | Preeclampsia | ACTIVATED PROTEIN-C | PROTHROMBIN G20210A MUTATION | GENETIC RISK-FACTORS | maternal outcome | preeclampsia | ELEVATED LIVER-ENZYMES | METHYLENETETRAHYDROFOLATE REDUCTASE | thrombophilia | GESTATIONAL HYPERTENSION | FACTOR-V-LEIDEN | FETAL INHERITED THROMBOPHILIAS | ANTIPHOSPHOLIPID-ANTIBODIES | PERIPHERAL VASCULAR DISEASE | perinatal outcome | LOW PLATELET COUNT | Pregnancy | Severity of Illness Index | Thrombophilia - genetics | Risk Assessment | Humans | Female | Heterozygote | Pre-Eclampsia - physiopathology | Thrombophilia - complications | Case-Control Studies | Pregnancy Outcome | Thrombophilia - etiology | Index Medicus
Journal Article
Details
Digital rights
Loading RightsLancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9955, pp. 1673 - 1683
Summary Background Thrombophilias are common disorders that increase the risk of pregnancy-associated venous thromboembolism and pregnancy loss and can also...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | RECURRENT MISCARRIAGE | MULTICENTER | RISK-FACTORS | EARLY-ONSET PREECLAMPSIA | LOW-DOSE ASPIRIN | VENOUS THROMBOEMBOLISM | FETAL LOSS | MOLECULAR-WEIGHT HEPARIN | GENETIC THROMBOPHILIA | THROMBOPROPHYLAXIS | Humans | Risk Factors | Dalteparin - adverse effects | Treatment Outcome | Thrombophilia - complications | Pregnancy Outcome - epidemiology | Pregnancy | Fibrinolytic Agents - adverse effects | Venous Thromboembolism - prevention & control | Dalteparin - therapeutic use | Pregnancy Complications, Cardiovascular - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Female | Hemorrhage - chemically induced | Thrombophilia - drug therapy | Pregnant women | Analysis | Anticoagulants | Placenta | Mortality | Preeclampsia | Drug therapy | Thrombosis | Drug dosages | Age | Index Medicus | Abridged Index Medicus
Internal Medicine | MEDICINE, GENERAL & INTERNAL | RECURRENT MISCARRIAGE | MULTICENTER | RISK-FACTORS | EARLY-ONSET PREECLAMPSIA | LOW-DOSE ASPIRIN | VENOUS THROMBOEMBOLISM | FETAL LOSS | MOLECULAR-WEIGHT HEPARIN | GENETIC THROMBOPHILIA | THROMBOPROPHYLAXIS | Humans | Risk Factors | Dalteparin - adverse effects | Treatment Outcome | Thrombophilia - complications | Pregnancy Outcome - epidemiology | Pregnancy | Fibrinolytic Agents - adverse effects | Venous Thromboembolism - prevention & control | Dalteparin - therapeutic use | Pregnancy Complications, Cardiovascular - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Female | Hemorrhage - chemically induced | Thrombophilia - drug therapy | Pregnant women | Analysis | Anticoagulants | Placenta | Mortality | Preeclampsia | Drug therapy | Thrombosis | Drug dosages | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading Rights